Circle K, triple antibiotic ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Pol...
FDA Drug Recall #D-0631-2026 - Class II, June 2, 2026
Recall Summary
| Recall Number | D-0631-2026 |
| Classification | Class II - Moderate risk |
| Date Initiated | June 2, 2026 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Dabur India Limited |
| Location | Dadra And Nagar Haveli |
| Product Type | Drugs |
| Quantity | 2420 tubes |
Product Description
Circle K, triple antibiotic ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B Sulfate (5000 units), net wt. 0.5 oz (14.2g) tubes, Product manufactured for Lil' Drug Store Products, Inc., 9300 Earhart Lane SW, Cedar Rapids, IA 52404, Made in India, UPC 1 94283 65181 0.
Reason for Recall
CGMP Deviations; deficiencies observed during FDA inspection
Distribution Pattern
US Nationwide.
Lot / Code Information
Lot# 0001, and Lot# 0005, within expiry
Other Recalls from Dabur India Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0642-2026 | Class II | Med Pride, Triple Antibiotic Ointment, Bacitrac... | Jun 2, 2026 |
| D-0636-2026 | Class II | Med Pride, Bacitracin Zinc Ointment, 500 units,... | Jun 2, 2026 |
| D-0632-2026 | Class II | Lil Drug Store, Triple Antibiotic Ointment, Bac... | Jun 2, 2026 |
| D-0638-2026 | Class II | Med Pride, 1% Clotrimazole Antifungal Cream, Ne... | Jun 2, 2026 |
| D-0639-2026 | Class II | Med Pride, HYDROCORTISONE CREAM 1%, Net Wt. 16o... | Jun 2, 2026 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice, the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful, in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.